This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, J. Articles by Lala, D. S. Search for Related Content PubMed PubMed Citation Articles by Wu, J. Articles by Lala, D. S.

The Hypolipidemic Natural Product Guggulsterone Acts as an Antagonist of the Bile Acid Receptor

Department of Biotechnology, Pharmacia Corp., St. Louis, Missouri 63198

Address all correspondence and requests for reprints to: Deepak S. Lala, Department of Biotechnology, Mail Zone AA305E, Pharmacia Corp., 700 Chesterfield Parkway North, St. Louis, Missouri 63198. E-mail: deepak.s.lala{at}pharmacia.com.

Ayurveda, the ancient Indian system of health care and medicine, has a well-organized materia medica in which plants form a dominant part. A key illustration of the exploitation of this knowledge toward the development of a modern drug is the isolation and characterization of two antihyperlipidemic compounds, Z-, and E-guggulsterone from the tree Commiphora mukul, the exudate of which has been traditionally used for mitigating lipid disorders. Here, we demonstrate that Z-guggulsterone and an analog, 80–574 currently in clinical trials, act as antagonists of the bile acid receptor (BAR), a member of the intracellular receptor superfamily. These compounds antagonize the activity of BAR in vitro, and in cell culture systems on promoters and endogenous target genes. In biochemical assays, they are able to displace coactivator peptides from the receptor in a dose-dependent manner. The mechanism by which they act as BAR antagonists is likely through their inability to recruit coactivator proteins, failure to release corepressor proteins from unliganded receptor, and ability to compete with BAR agonists to block coactivator recruitment. Our data suggest these compounds may mediate at least some of their effects via the BAR.

This article has been cited by other articles:

				P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation Physiol Rev, January 1, 2009; 89(1): 147 - 191. [Abstract] [Full Text] [PDF]

				J. D. Dietz, S. Du, C. W. Bolten, M. A. Payne, C. Xia, J. R. Blinn, J. W. Funder, and X. Hu A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity Hypertension, March 1, 2008; 51(3): 742 - 748. [Abstract] [Full Text] [PDF]

				D. Xiao and S. V. Singh z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo Mol. Cancer Ther., January 1, 2008; 7(1): 171 - 180. [Abstract] [Full Text] [PDF]

				S. V. Singh, S. Choi, Y. Zeng, E.-R. Hahm, and D. Xiao Guggulsterone-Induced Apoptosis in Human Prostate Cancer Cells Is Caused by Reactive Oxygen Intermediate Dependent Activation of c-Jun NH2-Terminal Kinase Cancer Res., August 1, 2007; 67(15): 7439 - 7449. [Abstract] [Full Text] [PDF]

				R. Deng, D. Yang, A. Radke, J. Yang, and B. Yan The Hypolipidemic Agent Guggulsterone Regulates the Expression of Human Bile Salt Export Pump: Dominance of Transactivation over Farsenoid X Receptor-Mediated Antagonism J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1153 - 1162. [Abstract] [Full Text] [PDF]

				S. Wang, K. Lai, F. J. Moy, A. Bhat, H. B. Hartman, and M. J. Evans The Nuclear Hormone Receptor Farnesoid X Receptor (FXR) Is Activated by Androsterone Endocrinology, September 1, 2006; 147(9): 4025 - 4033. [Abstract] [Full Text] [PDF]

				H. Ichikawa and B. B. Aggarwal Guggulsterone Inhibits Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor-{kappa}B Ligand and by Tumor Cells by Suppressing Nuclear Factor-{kappa}B Activation Clin. Cancer Res., January 15, 2006; 12(2): 662 - 668. [Abstract] [Full Text] [PDF]

				E. A. Hanniman, G. Lambert, T. C. McCarthy, and C. J. Sinal Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice J. Lipid Res., December 1, 2005; 46(12): 2595 - 2604. [Abstract] [Full Text] [PDF]

				S. V. Singh, Y. Zeng, D. Xiao, V. G. Vogel, J. B. Nelson, R. Dhir, and Y. B. Tripathi Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak Mol. Cancer Ther., November 1, 2005; 4(11): 1747 - 1754. [Abstract] [Full Text] [PDF]

				K. R. Stayrook, K. S. Bramlett, R. S. Savkur, J. Ficorilli, T. Cook, M. E. Christe, L. F. Michael, and T. P. Burris Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor Endocrinology, March 1, 2005; 146(3): 984 - 991. [Abstract] [Full Text] [PDF]

				T. P. Burris, C. Montrose, K. A. Houck, H. E. Osborne, W. P. Bocchinfuso, B. C. Yaden, C. C. Cheng, R. W. Zink, R. J. Barr, C. D. Hepler, et al. The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand Mol. Pharmacol., March 1, 2005; 67(3): 948 - 954. [Abstract] [Full Text] [PDF]

				S. Shishodia and B. B. Aggarwal Guggulsterone Inhibits NF-{kappa}B and I{kappa}B{alpha} Kinase Activation, Suppresses Expression of Anti-apoptotic Gene Products, and Enhances Apoptosis J. Biol. Chem., November 5, 2004; 279(45): 47148 - 47158. [Abstract] [Full Text] [PDF]

				D. E. Brobst, X. Ding, K. L. Creech, B. Goodwin, B. Kelley, and J. L. Staudinger Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 528 - 535. [Abstract] [Full Text] [PDF]

				A. Bianchi, P. Cantu, F. Firenzuoli, G. Mazzanti, F. Menniti-Ippolito, and R. Raschetti Rhabdomyolysis Caused by Commiphora mukul, a Natural Lipid-Lowering Agent Ann. Pharmacother., July 1, 2004; 38(7): 1222 - 1225. [Abstract] [Full Text] [PDF]

				V. R. Karuparthy and S. Vepachedu Guggulipid and Cholesterol Levels JAMA, December 3, 2003; 290(21): 2800 - 2801. [Full Text] [PDF]

				K. S. Bramlett, K. A. Houck, K. M. Borchert, M. S. Dowless, P. Kulanthaivel, Y. Zhang, T. P. Beyer, R. Schmidt, J. S. Thomas, L. F. Michael, et al. A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 291 - 296. [Abstract] [Full Text] [PDF]

				P. O. Szapary, M. L. Wolfe, L. T. Bloedon, A. J. Cucchiara, A. H. DerMarderosian, M. D. Cirigliano, and D. J. Rader Guggulipid for the Treatment of Hypercholesterolemia: A Randomized Controlled Trial JAMA, August 13, 2003; 290(6): 765 - 772. [Abstract] [Full Text] [PDF]

				G. S. Grover, B. A. Turner, C. N. Parker, J. Meier, D. S. Lala, and P. H. Lee Multiplexing Nuclear Receptors for Agonist Identification in a Cell-Based Reporter Gene High-Throughput Screen J Biomol Screen, June 1, 2003; 8(3): 239 - 246. [Abstract] [PDF]

				X. Hu, S. Li, J. Wu, C. Xia, and D. S. Lala Liver X Receptors Interact with Corepressors to Regulate Gene Expression Mol. Endocrinol., June 1, 2003; 17(6): 1019 - 1026. [Abstract] [Full Text] [PDF]

				J. Cui, L. Huang, A. Zhao, J.-L. Lew, J. Yu, S. Sahoo, P. T. Meinke, I. Royo, F. Pelaez, and S. D. Wright Guggulsterone Is a Farnesoid X Receptor Antagonist in Coactivator Association Assays but Acts to Enhance Transcription of Bile Salt Export Pump J. Biol. Chem., March 14, 2003; 278(12): 10214 - 10220. [Abstract] [Full Text] [PDF]

				I. Dussault, R. Beard, M. Lin, K. Hollister, J. Chen, J.-H. Xiao, R. Chandraratna, and B. M. Forman Identification of Gene-selective Modulators of the Bile Acid Receptor FXR J. Biol. Chem., February 21, 2003; 278(9): 7027 - 7033. [Abstract] [Full Text] [PDF]

				G. Lambert, M. J. A. Amar, G. Guo, H. B. Brewer Jr., F. J. Gonzalez, and C. J. Sinal The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis J. Biol. Chem., January 17, 2003; 278(4): 2563 - 2570. [Abstract] [Full Text] [PDF]